HIGHLIGHTS
- who: Maria Raquel Moita from the University Hospital Erlangen, Germany have published the research work: Transcriptome and proteome profiling of activated cardiac fibroblasts supports target prioritization in cardiac fibrosis, in the Journal: (JOURNAL)
- what: Thereby the authors provide a panel of putative novel targets for cardiac fibrosis. The authors demonstrate that hiPSC-CF is a suitable and sustainable cell source for in_vitro drug discovery displaying a significantly lower basal activation level as compared with primary cells, while retaining the ability to elicit a convergent response relative to primary cells upon stimuli. The aim of this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.